首页> Clinical lymphoma, myeloma & leukemia> Late Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era.

Late Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era.

导出 LinkOut

翻译打印收藏纠错

第一作者： Bradley D,Hunter

第一单位： Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA.

作者： Bradley D,Hunter ^[1] ; Megan,Herr ^[2] ; Philip J,Meacham ^[2] ; Ferdous,Barlaskar ^[3] ; Andrew G,Evans ^[4] ; W Richard,Burack ^[4] ; Jane L,Liesveld ^[5] ; Michael W,Becker ^[5] ; Laurie A,Milner ^[6] ; Louis S,Constine ^[7] ; Sughosh,Dhakal ^[7] ; Paul M,Barr ^[5] ; Jonathan W,Friedberg ^[5] ; Carla,Casulo ^[8]

作者单位： Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA. ^[1] Division of Epidemiology, Department of Public Health Sciences, University of Rochester, Rochester, NY. ^[2] Department of Medicine, Yale New Haven Medical Center, New Haven, CT. ^[3] Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY. ^[4] Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester, Rochester, NY. ^[5] Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY; Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester, Rochester, NY. ^[6] Department of Radiation Oncology, James P. Wilmot Cancer Institute, University of Rochester, Rochester, NY. ^[7] Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester, Rochester, NY. Electronic address: Carla_Casulo@URMC.Rochester.edu. ^[8]

关键词 Autologous stem cell transplant DLBCL Early relapse Refractory Relapse